Aemetis Price Target Raised by Ascendiant Capital to $20.00 USD.
ByAinvest
Sunday, Jun 8, 2025 9:21 pm ET1min read
AMTX--
The average one-year price target for Aemetis, as forecasted by five analysts, stands at $10.44, indicating a substantial upside of 506.98% from the current price of $1.72. The consensus brokerage recommendation for Aemetis is 2.4, indicating an "Outperform" status. Additionally, GuruFocus estimates the company's GF Value to be $6.39, suggesting a potential upside of 271.51% from the current price [3].
Aemetis, a company involved in the development of renewable fuels and chemicals, has been the subject of investor interest due to its growth potential in the renewable energy sector. The company reported its Q1 2025 earnings, revealing a revenue shortfall with $42.9 million, significantly below the forecasted $56.89 million. The company also posted an earnings per share (EPS) of -$0.47, missing the expected -$0.40. This decline in revenue was largely attributed to delayed biodiesel contracts in India [1].
Despite these challenges, Aemetis continues to invest in renewable energy projects, including dairy renewable natural gas (RNG) and ethanol production. In a strategic move, Aemetis signed a $27 million agreement with Centuri Holdings for biogas system expansion, aiming to enhance RNG production from dairy waste. Additionally, Aemetis held its Annual Meeting of Stockholders, where Eric A. McAfee and Francis P. Barton were re-elected to the board, and stockholders ratified the appointment of RSM US LLP as the independent auditor for the fiscal year 2025. The company is also preparing for a subsidiary IPO in India and exploring expansion opportunities in the region. These developments highlight Aemetis’s ongoing efforts to strengthen its renewable energy initiatives amid financial challenges [1].
References:
[1] https://za.investing.com/news/analyst-ratings/ascendiant-capital-raises-aemetis-stock-price-target-to-20-93CH-3746526
[2] https://www.gurufocus.com/news/2912423/aemetis-amtx-receives-target-price-boost-amid-positive-longterm-outlook-amtx-stock-news
[3] https://www.gurufocus.com/news/2912559/aemetis-amtx-sees-price-target-raised-by-ascendiant-capital-amtx-stock-news
[4] https://www.marketbeat.com/instant-alerts/aemetis-nasdaqamtx-price-target-raised-to-2000-at-ascendiant-capital-markets-2025-06-06/
Ascendiant Capital analyst Edward Woo raised the price target for Aemetis (AMTX) to $20.00, a 5.26% increase, while maintaining a "Buy" rating. The average one-year price target is $10.44, indicating a 506.98% upside from the current price of $1.72. Aemetis' average brokerage recommendation is 2.4, indicating "Outperform" status. The estimated GF Value is $6.39, suggesting a 271.51% upside from the current price.
Ascendiant Capital analyst Edward Woo has recently adjusted the price target for Aemetis (AMTX) to $20.00, marking a 5.26% increase from the previous target of $19.00. Despite this upward revision, Woo maintains a "Buy" rating for the company's shares, reflecting ongoing confidence in Aemetis' market position and potential for growth [3].The average one-year price target for Aemetis, as forecasted by five analysts, stands at $10.44, indicating a substantial upside of 506.98% from the current price of $1.72. The consensus brokerage recommendation for Aemetis is 2.4, indicating an "Outperform" status. Additionally, GuruFocus estimates the company's GF Value to be $6.39, suggesting a potential upside of 271.51% from the current price [3].
Aemetis, a company involved in the development of renewable fuels and chemicals, has been the subject of investor interest due to its growth potential in the renewable energy sector. The company reported its Q1 2025 earnings, revealing a revenue shortfall with $42.9 million, significantly below the forecasted $56.89 million. The company also posted an earnings per share (EPS) of -$0.47, missing the expected -$0.40. This decline in revenue was largely attributed to delayed biodiesel contracts in India [1].
Despite these challenges, Aemetis continues to invest in renewable energy projects, including dairy renewable natural gas (RNG) and ethanol production. In a strategic move, Aemetis signed a $27 million agreement with Centuri Holdings for biogas system expansion, aiming to enhance RNG production from dairy waste. Additionally, Aemetis held its Annual Meeting of Stockholders, where Eric A. McAfee and Francis P. Barton were re-elected to the board, and stockholders ratified the appointment of RSM US LLP as the independent auditor for the fiscal year 2025. The company is also preparing for a subsidiary IPO in India and exploring expansion opportunities in the region. These developments highlight Aemetis’s ongoing efforts to strengthen its renewable energy initiatives amid financial challenges [1].
References:
[1] https://za.investing.com/news/analyst-ratings/ascendiant-capital-raises-aemetis-stock-price-target-to-20-93CH-3746526
[2] https://www.gurufocus.com/news/2912423/aemetis-amtx-receives-target-price-boost-amid-positive-longterm-outlook-amtx-stock-news
[3] https://www.gurufocus.com/news/2912559/aemetis-amtx-sees-price-target-raised-by-ascendiant-capital-amtx-stock-news
[4] https://www.marketbeat.com/instant-alerts/aemetis-nasdaqamtx-price-target-raised-to-2000-at-ascendiant-capital-markets-2025-06-06/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet